youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
153,43 $
arrow_downward
-8,99%(-15,15) 1D
137,49 $
arrow_downward
-10,39% (-15,94)bedtimeAfter hours
Closed: 5 նոյ, 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
165,00 $
High
165,10 $
Low
151,92 $
Mkt. cap
20,59 մլրդ
Avg. vol.
1,81 մլն
Volume
0,00
52-wk high
191,01 $
52-wk low
74,55 $
EPS
-3,50 $
Beta
1,67
Shares outstanding
134,20 մլն
No. of employees
2 հզր
Open
165,00 $
High
165,10 $
Low
151,92 $
Mkt. cap
20,59 մլրդ
Avg. vol.
1,81 մլն
Volume
0,00
52-wk high
191,01 $
52-wk low
74,55 $
EPS
-3,50 $
Beta
1,67
Shares outstanding
134,20 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Zacks
·
7 ժամ առաջ
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Securities.io
·
7 ժամ առաջ
Guardant Health Lifts 2026 Revenue Outlook as Screening Surges
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com